Aegon 2024 results show operating capital generation of €1.3bn

Aegon’s 2024 results confirm operating capital generation of €1.2bn, meeting upgraded guidance and showing a balance sheet and cash profile strong enough to support higher dividends and continued buybacks. For insurance CIOs and capital managers, the numbers point to a group increasingly run off the cash and capital engine rather than pure IFRS earnings, with asset management flows and international value creation doing more of the heavy lifting.

Implications for insurance CIOs and capital managers • Aegon has effectively hit its targeted €1.2bn operating capital generation run‑rate, signalling a more predictable upstreaming profile from its units into the holding. • Free cash flow of €759m, above guidance, and €1.7bn cash at holding increase visibility on the group’s ability to fund dividends, buybacks and potential reinvestment in capital‑intensive lines. • The combination of a 19% higher final dividend and ongoing buybacks points to a shareholder‑yield‑first capital policy, which may constrain large-scale inorganic expansion but supports equity valuations.

• Strong third‑party net deposits of about €14bn at Aegon AM reinforce the strategic tilt toward fee‑based, capital‑light earnings, with implications for the mix of mandates and risk appetite in its investment platforms. • International life is being repriced for lower rates, with 15% lower new life sales but 18% higher value of new business, indicating a clear preference for margin and capital efficiency over volume. • With gross financial leverage expected to remain around €5bn, balance sheet optimisation now depends more on capital generation and cash discipline than on further de‑leveraging.

Capital generation and cash: from guidance to delivery

Aegon reported operating capital generation of €1.2bn for 2024, explicitly stating that it met its increased guidance for the year. This validates management’s earlier assertion that the “next chapter” of the strategy would support around €1.2bn of operating capital generation from its units by 2025.

Operating capital generation before holding funding and operating expenses was €658m in the second half, described as broadly stable, which suggests a relatively even contribution profile across the year rather than a back‑loaded outcome. For ALM teams, that stability matters: it points to a capital engine less dependent on one‑off management actions and more on recurring spread, fee and underwriting results. Free cash flow for 2024 came in at €759m, exceeding guidance of “more than €700m”. Management highlighted that this free cash flow figure includes capital distributions from a.s.r., underlining the importance of the Dutch partnership as a recurring cash source rather than just a one‑time transaction. With cash capital at holding of €1.7bn at year‑end, Aegon is running a sizeable buffer over typical management minima, giving it room to sustain shareholder distributions and absorb volatility in local entity remittances.

On an IFRS basis, the full‑year operating result was €1.5bn, providing an earnings backdrop that is broadly aligned with the capital generation narrative. In the second half alone, the operating result improved 14% year‑on‑year to €776m, while net profit reached €741m, indicating that earnings quality has been sufficient to support both capital generation and cash.

Capital return and balance sheet stance

The 2024 final dividend proposal of €0.19 per common share represents a 19% increase on the prior year’s final dividend, signalling growing confidence in the sustainability of cash flows. This sits alongside a stated ambition to grow dividend per share to around €0.40 over 2025, effectively pre‑committing a higher payout trajectory that will need to be underpinned by continued capital generation and disciplined risk selection.

Share buybacks have become a core component of Aegon’s capital management toolkit. The group completed a €1.535bn buyback in June, followed by a further €200m buyback in December. It also announced a new €150m buyback in the third quarter, expected to complete in the first half of 2025, and has already started this programme in January 2025. For investors in insurance equity and hybrid capital, this pattern of recurring buybacks, layered on top of a rising ordinary dividend, reinforces the perception of a structurally cash‑generative, capital‑light group.

At the same time, gross financial leverage is expected to remain around €5bn, suggesting that management is comfortable with the current debt stack and is prioritising distributions over rapid de‑leveraging. For credit investors and regulators, the message is that balance sheet optimisation will be incremental and funded by ongoing capital generation rather than by shrinking the liability side. Valuation equity per share, Aegon’s internal measure of shareholder value, increased 12% to €8.91 in 2024, indicating that the combination of capital return and business mix shift is also accretive on a value basis. That metric will be closely watched by boards and CIOs as a gauge of whether continued buybacks remain value‑creative versus alternative uses of capital. Business mix: asset management and international life

Aegon Asset Management delivered around €14bn of third‑party net deposits across its Global Platforms and Strategic Partnerships in 2024. For insurance allocators, this shows Aegon AM’s positioning as a scale player in outsourced mandates, with growing fee income that does not consume group capital and can support holding‑level cash flows. In the International business, new life sales fell 15%, mainly due to pricing actions in China to reflect lower interest rates. However, value of new business in the same segment grew 18%, driven by Brazil and Spain & Portugal, highlighting a deliberate pivot toward higher‑margin, more capital‑efficient products and geographies. For peers, this is a clear case study in trading volume for value when the rate environment and capital framework make legacy guarantees unattractive. Outlook

The key constraint now is execution: sustaining roughly €1.2bn of operating capital generation while maintaining €5bn of gross leverage and delivering the targeted step‑up in dividends and buybacks. For insurance CIOs, the next decision point will be whether Aegon can keep compounding valuation equity per share while running a shareholder‑yield‑heavy capital policy through the next rate and credit cycle.

--- Sources: https://www.aegon.com/investors https://www.aegon.com/newsroom/news/press-releases/2025/pr-2h-2024 https://www.reinsurancene.ws/aegon-sees-e741m-net-profits-in-h224-operating-result-climbs-14/